Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review.
Saved in:
| Title: | Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review. |
|---|---|
| Authors: | Hammed A; Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany., Al-Qiami A; Faculty of Medicine and Health Sciences, Kassala University, P.O. Box 1266, Kassala 21111, Sudan., Hasan A; Department of Oncology and Palliative Care, Helios Klinikum Bad Saarow, Brandenburg, Germany., Richter G; Department of Neuroradiology, Diakonie Hospital Jung Stilling, Siegen, Germany., Zakria Alnajjar A; Faculty of Medicine, Al-Azhar University, Gaza, Palestine., Rosenbauer J; Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany., Kostev K; University Hospital, Philipps University Marburg, Marburg, Germany., Ismail O; Department of Neuroradiology, Diakonie Hospital Jung Stilling, Siegen, Germany., Braun V; Department of Neurosurgery, Diakonie Hospital Jung Stilling, Siegen, Germany., Tanislav C; Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany. |
| Source: | Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2025 Jun 14; Vol. 18, pp. 17562864251343574. Date of Electronic Publication: 2025 Jun 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
